期刊文献+

术前血清CEA水平对结直肠癌术后复发的预测价值 被引量:1

Prognostic Value of Preoperative Serum Carcinoembryonic Antigen Level in Predicting Recurrence of Colorectal Cancer after Radical Surgery
下载PDF
导出
摘要 目的探究术前血清癌胚抗原(CEA)水平与结直肠癌术后复发的关系。方法回顾性分析164例结直肠癌根治术治疗的患者,跟踪随访上述病例并分析相关临床病理学指标及术前CEA水平同复发的关系。结果 CEA升高组的术后复发率较高(54.9%),与CEA正常组相比,差异有统计学意义(P<0.05)。多因素分析表明,术前血清CEA水平、肿瘤分期与结直肠癌术后复发率阳性相关(P=0.003).结论术前血清CEA水平是预测结直肠癌术后复发问题的独立指标,术前血清CEA水平对结直肠癌根治术患者的治疗计划是有指导意义的。 Objective To evaluate the prognostic value of preoperative serum carcinoembryonic antigen (CEA) level in patients with colorectal cancer. Methods This retrospective study included 164 colorectal cancer patients aged from 25 to 69 years, surgically treated between April 2006 and October 2009. Correlation between postoperative recurrence and clinic pathological features or preoperative serum CEA levels was analyzed. Results Comparing with the normal CEA group, postoperative recurrence rate in elevated CEA group (54. 9% ) increased significantly (P 〈 0. 05 ). Multivariate analysis indicated that both preoperative serum CEA levels and tumor stage correlated positively to postoperative recurrence rate of colorectal cancer patients ( P = 0. 003 ). Conclusion Preoperative serum CEA is a reliable predictor factor for recurrence in patients with colorectal cancer. CEA might be used in treatment planning in colorectal cancer patients undergoing curative resection.
出处 《四川医学》 CAS 2014年第4期459-461,共3页 Sichuan Medical Journal
关键词 癌胚抗原 结直肠癌 预后因素 carcinoembryonic antigen colorectal cancer prognostic factor
  • 相关文献

参考文献10

  • 1McCall JL, Black RB,Toouli J,et al. The value of serum carcinoembry- onie antigen in predicting recurrent disease following curative resection of eolorectal cancer[ ] ]. Dis Colon Rectum,1994,37 (9) :875-881.
  • 2Lipska'L,Visokai V,Levy'M,et al. Tumor markers in patients with re- lapse of colorectal carcinoma [ J ]. Anticancer Res, 2007, 27 (4A) :1901-1905.
  • 3Watine J, Miedouge M, Friedberg B. Carcinoembryonic antigen as anindependent prognostic factor of recurrence and survival in patients re- sected for colorectal liver metastases: a systematic review [ J ]. Dis Co- lon Rectum,2001,44 (12) :1791-1799.
  • 4Wiratkapun S, Kraemer M, Eu KW,et aL High preoperative serum car- cinocmbryonic antigen predicts metastatic recur/ence in potentially cur- ative colonic cancer: results of a five-year study [ J ]. Dis Colon Rec- tum,g004,44 (2) :231-235.
  • 5Edge SB,Compton CC. The American Joint Committee on Cancer- the 7th edition of the AJCC cancer staging manual and the future of TNM [J]. Ann Surg Oncol,2010,17(6) :1471-1474.
  • 6Forslund A, Engaras B, Lonnroth C, et al. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CAS0, CA242 and conventional blood tests in patients with colorectal carcinoma[ J]. Int J Onco1,2000 20 (5) : 1013-1018.
  • 7胡书生,王慜杰,高佳,齐军.术前血清CEA在结直肠癌患者预后判断上的作用[J].标记免疫分析与临床,2012,19(6):333-337. 被引量:6
  • 8廉朋,徐烨,蔡国响,彭俊杰,蔡三军.术前CEA、CA19-9和CA50的表达水平与结直肠癌临床病理特点的相关性研究——附1340例病例分析[J].临床肿瘤学杂志,2006,11(5):326-330. 被引量:25
  • 9李四光,魏光兵,王康,仇广林,柴明明.血清CEA阳性对结直肠癌临床诊断、术前评估及预后意义的研究[J].陕西医学杂志,2012,41(8):1030-1032. 被引量:6
  • 10Takagawa R, Fujii S, Ohta M, et al. Preoperative serum carcinoembry- onic antigen level as a predictive factor of recurrence after curative re- section of colorectal cancer [ J ]. Ann Surg Oneol, 2008, 15 (12) :3433-3439.

二级参考文献18

  • 1吕洋,刘博,吴靖芳.大肠癌相关生物标志物的病理学进展[J].河北北方学院学报(医学版),2007,24(1):80-82. 被引量:9
  • 2Gold P,Freedman SO.Demonstration of tumor-specific antigens in human colonic carcinoma b11 immunological tolerance and adsorption techniques [J].J Exp Med,1965,121:439-462.
  • 3Bresalier RS.Malignant neoplasms of large intestine.In:M.Feldman,L.S.Freidman,and M.H.Sleisenger,editors.Sleisenger and Fordtrans gastrointestinal and liver disease[M].Philadelphia:W.B Saunders,2002.2215-2261.
  • 4Compton C,Fenoglio-Preiser CM,Pettigrew N,et al.American joint committee on cancer prognostic factors consensus conference:Colorectal work group[J].Cancer,2000,88:1739-1757.
  • 5Chien-Chih C,Shung-HaurY,Jen-Kou L,et al.Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?[J] Journal of Surgical Research,2005,124:169-174.
  • 6Shunji M,Takashi N,Yukio F,et al.Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?[J] Dis Colon Rectum,2004,47:227-232.
  • 7Robert JM,Anurag S,Elisa HB,et al.Pretreatment clinical findings predict outcome for patients receiving preoperative radiation for rectal cancer[J].Int J Radiation Oncology Biol Phys,2001,50(3):665-674.
  • 8Jeffrey AM,Robert JM.Follow-up strategies after curative resection of colorectal cancer[J].Seminars in Oncology,2003,30(3):349-360.
  • 9Mccall J,Black RB,Rich CA,et al.The value of serum carcino-embryonic antigen in predicting recurrent disease following curative resection of colorectal cancer[J].Dis Colon Rectum,1994,37:875-881.
  • 10Johanna L,Monika CH,Henrik A,et al.Serum HCGβ,CA72-4,and CEA are independent prognostic factors in colorectal cancer[J].Int J Cancer,2002,101:545-548.

共引文献33

同被引文献8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部